Education
About Us
Working with TipRanks
Follow Us
Biotest AG (DE:BIO3)
HAMBURG:BIO3
BIO3 Stock Chart & Stats
€31.40
-€0.40(-1.46%)
At close: 4:00 PM EST
€31.40
-€0.40(-1.46%)
Day’s Range― - ―
52-Week Range€25.00 - €34.00
Previous CloseN/A
Volume6.32K
Average Volume (3M)729.00
Market Cap
€1.33B
Enterprise ValueN/A
Total Cash (Recent Filing)€119.50M
Total Debt (Recent Filing)€597.20M
Price to Earnings (P/E)―
Beta>-0.01
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.13%
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,785,727
10 Day Avg. Volume974
30 Day Avg. Volume729
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.29
Revenue Forecast (FY)€613.48M
Biotest News
BIO3 FAQ
What was Biotest AG’s price range in the past 12 months?
Biotest AG lowest stock price was €25.00 and its highest was €34.00 in the past 12 months.
What is Biotest AG’s market cap?
Biotest AG’s market cap is €1.33B.
When is Biotest AG’s upcoming earnings report date?
Biotest AG’s upcoming earnings report date is Mar 26, 2026 which is in 98 days.
How were Biotest AG’s earnings last quarter?
Currently, no data Available
Is Biotest AG overvalued?
According to Wall Street analysts Biotest AG’s price is currently Overvalued.
Does Biotest AG pay dividends?
Biotest AG pays a Annually dividend of €0.04 which represents an annual dividend yield of 0.13%. See more information on Biotest AG dividends here
What is Biotest AG’s EPS estimate?
Biotest AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotest AG have?
Biotest AG has 19,785,727 shares outstanding.
What happened to Biotest AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biotest AG?
Currently, no hedge funds are holding shares in DE:BIO3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Biotest Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Biotest AG
Biotest AG (BIO3) is a global biotechnology company that specializes in the development, production, and marketing of high-quality plasma proteins for the treatment of immunological and hematological disorders. The company's portfolio includes products such as immunoglobulins, clotting factors, and other plasma-derived therapies. Biotest operates in the biopharmaceutical sector and focuses on providing innovative solutions for patients with complex health conditions, leveraging advanced technologies in its manufacturing processes.
Technical Analysis
Eckert & Ziegler Strahlen und Medizintechnik
―
Evotec
―
Dermapharm Holding SE
―
Medios AG
―
Formycon AG
―